Adenoviral vectors : a possible road to an HIV vaccine

Titlepage

Contents

Chapter 1: Introduction

Chapter 3: Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys

Chapter 4: Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity

Chapter 5: Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

Chapter 6: Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity

Chapter 7: Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroup B and D

Chapter 8: General discussion

References

Summary

Samenvatting

Curriculum Vitae

List of publications

Dankwoord